As of right now, GreenLight Biosciences Holdings [GRNA] is trading at $0.20, up 11.03%. An important factor to consider is whether the stock is rising or falling in short-term value. The GRNA shares have gain 1.39% over the last week, with a monthly amount drifted -38.44%, and not seem to be holding up well over a long-time horizon.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
On 11, May 2023, GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress. In a post published today on Yahoo Finance, Image: GreenLight Biosciences.
From an analyst’s perspective:
Through the last year, GreenLight Biosciences Holdings’s stock price ranged from $0.18 to $8.34. Currently, Wall Street analysts expect the stock to reach $2.30 within the next 12 months. GreenLight Biosciences Holdings [NASDAQ: GRNA] shares were valued at $0.20 at the most recent close of the market. An investor can expect a potential return of 1050.0% based on the average GRNA price forecast.
Analyzing the GRNA fundamentals
Gross Margin for this corporation currently stands at -113.85% with Operating Margin at -2558.83%, Pretax Margin comes in at -2599.67%, and Net Margin reading is -2616.78%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1805 points at the first support level, and at 0.1647 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2116, and for the 2nd resistance point, it is at 0.2269.
GreenLight Biosciences Holdings [GRNA] reported earnings per share of -$0.25 for its fiscal quarter that ended on 12/30/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.25/share, meaning a difference of $0 and a surprise factor of 0.00%.
Ratios To Look Out For
It is important to note that GreenLight Biosciences Holdings [NASDAQ:GRNA] has a current ratio of 1.20. On the other hand, the Quick Ratio is 2.01, and the Cash Ratio is 1.91. Considering the valuation of this stock, the price to sales ratio is 24.39, the price to book ratio is 3.72.
Transactions by insiders
Recent insider trading involved Builders Vision, LLC, 10% Owner, that happened on Aug 11 when 6.51 million shares were purchased. Director, Walker Matthew Allen completed a deal on Aug 11 to buy 6.38 million shares. Meanwhile, 10% Owner Morningside Venture Investment bought 3.06 million shares on Aug 11.